on GENFIT (EPA:GNFT)
GENFIT's Annual Meeting: Preparatory Documents Available
GENFIT, a biopharmaceutical company specializing in liver diseases, has announced the availability of preparatory documents for its upcoming Annual Combined General Meeting on June 15, 2026. The meeting will occur at the Faculty of Pharmaceutical Sciences in Lille, France, and broadcasted live on GENFIT's website. Shareholders can access the meeting materials in line with regulations via the company's Financials section under the Shareholders Meeting tab.
Shareholders can vote online using the VOTACCESS platform, available from May 27, 2026, following the meeting notice's publication in the official French BALO bulletin. A tutorial for online voting will be accessible on GENFIT's website to assist shareholders.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all GENFIT news